I'm absolutely thrilled that this we're clearly going to have the best conversation in the fireside chat that we've had so far. Incredibly pleased to have Emma Walmsley here. She's CEO and on the ...
Pharmaceutical Technology on MSN
GSK sells liver disease drug candidate to Alfasigma for $690m
GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.
GlaxoSmithKline has expanded its “Target the Future” campaign to include the “Think Tank Challenge.” The competition, open to individuals, advocacy groups and anyone/everyone else, will award £70,000 ...
Emma Walmsley, GSK CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent earnings, innovation pipeline, the potential impact of tariffs on pharmaceuticals, and much more. Got a ...
Under the terms of the agreement, Alfasigma is expected to acquire worldwide exclusive rights to develop, manufacture and commercialize linerixibat, while GSK will receive an upfront payment of $300 ...
GSK committed $270 million up front in recent months to gain access to early-stage assets in the class of cancer therapies known as antibody drug conjugates, or ADCs. The deals are part of a broad ...
In GSK’s second-quarter earnings discussions, the company presented itself as a “new focused biopharma company.” It’s the first call since the July 18 demerger of its consumer health unit, now dubbed ...
Shortly after finding success with a digital collaboration combining the expertise of universities and major pharma players like AstraZeneca and GSK, the United Kingdom’s Centre for Process Innovation ...
GlaxoSmithKline has signed a multiyear partnership agreement with artificial intelligence-powered pathology company PathAI, according to an April 5 news release. The partnership will focus on ...
PHILADELPHIA--(BUSINESS WIRE)--GSK plc today announced the first recipient of the Target the Future Think Tank Challenge £70,000 (equivalent to approximately $100,000) grant to the HealthTree ...
Alexandria, Va., USA – The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer Healthcare today announced the 2010 winners of the annual IADR/GSK Innovation in Oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results